Oligonucleotide Synthesis Market
The oligonucleotide synthesis market is expected to gain a market value
of USD 27.2619 billion by 2030 at a CAGR of 16.50 % over the
forecast period of 2023-2030. The market over the review period is also
expected to earn substantial valuation. The chemical synthesis of the nucleic
acids with definite chemical structures is known as oligonucleotide synthesis.
Its ability to produce results regarding customized nucleotides rapidly through
inexpensive methods is making it choicest preference for a lot of research
laboratories that are spending heavily in developing biotechnologies. The
desired oligonucleotide requires a perfect oligonucleotide chain which can
easily be made in laboratories. The completion of the chain sees a release from
the solid phase to the solution, deprotected, and collected. MRFR in their
recent report on the oligonucleotide synthesis market distinctly studied segments
with their proper valuation both value-wise and volume-wise to understand the
market comprehensively. Factors that can impact the market in the coming years
have also been included for a critical overview of the oligonucleotide
synthesis market.
Ventures and
investments from big companies in the oligonucleotide synthesis market can
prove beneficial in the coming years. Gene study can provide much-needed
traction, and the market can witness substantial rise during the forecast
period. But the cost associated with it can be a major factor, and lack of
adept hands can be a market deterrent.
Major Key
Players:
The Oligonucleotide Synthesis
Market Players, as
described by MRFR, are GE Healthcare (U.S.), Integrated DNA Technologies, Inc
(U.S), Eurogentec S.A (Belgium), Sigma-Aldrich Corporation (U.S.),
Bioautomation Corporation (U.S.), Agilent Technologies Inc. (U.S.), Thermo
Fisher Scientific Inc. (U.S.), Eurofins Genomics (Germany), L.G.C Biosearch
Technologies (U.S.), Nitto Denko Avecia Inc. (Japan), and others.
Segment Analysis
MRFR, for a better understanding of the oligonucleotide
synthesis market, segmented the market by product type, application, and
end-users.
Based on the product type, the oligonucleotide
synthesis market can be segmented into synthesized oligonucleotides, reagents
and equipment. The synthesized oligonucleotides segment has a substantial hold
over the market.
Based on the application, the oligonucleotide
synthesis market can be segmented into library preparation, diagnostic,
research, therapeutics, genetic testing, gene synthesis, drug target screening, and others. Drug target
screening is quite popular as it gets substantial traction from the
pharmaceutical sector.
Based on the end-users, the oligonucleotide synthesis
market can be segmented into academic research institutes, diagnostic
laboratories, and pharmaceutical & biotechnology companies. Diagnostic laboratories are expected to record
considerable growth during the forecast period.
Regional Analysis
Region-specific segmentation of
the oligonucleotide synthesis market, as discussed in the MRFR report, includes
North America, Europe, Asia Pacific (APAC), and the Middle East & Africa
(MEA).
The rise of North America can be
attributed to the constant search for better treatment. The robust healthcare
structure and the infrastructure of the research centers are quite indicative
of that. Regional endeavor for such things is getting mostly driven by chronic
diseases such as cancer and diabetes. Governments and private investors are
equally funding for innovation in the sector, and it can take the regional
market further ahead.
Europe is getting driven by the
same intents like that of North America and is getting amply backed by research
centers and government initiatives. Funding for the regional market is not a
big problem as many pharmaceutical companies from the region are investing
substantially in understanding the gene sequence to develop better drugs. The
APAC region is expected to rise significantly as many of the global titans are
looking at the region as a possible investment opportunity. Infrastructural
benefits and low cost of resources are some alluring factors that are
controlling the market.
About Market Research
Future
At Market Research Future (MRFR), we enable our
customers to unravel the complexity of various industries through our Cooked
Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research
Reports (3R), Continuous-Feed Research (CFR), and Market Research &
Consulting Services.
MRFR team have supreme objective to provide the
optimum quality market research and intelligence services to our clients. Our
market research studies by products, services, technologies, applications, end
users, and market players for global, regional, and country level market
segments, enable our clients to see more, know more, and do more, which help to
answer all their most important questions.
In order to stay updated with technology and work
process of the industry, MRFR often plans & conducts meet with the industry
experts and industrial visits for its research analyst members.
Contact us:
Market Research Future
(part of Wantstats Research and Media Private Limited),
99 Hudson Street, 5Th Floor,
New York, New York 10013
United States of America
+1 646 845 9312
